| Author | Heimpel, Hermann | dc.contributor.author |
| Date of accession | 2018-06-26T05:53:30Z | dc.date.accessioned |
| Available in OPARU since | 2018-06-26T05:53:30Z | dc.date.available |
| Date of first publication | 1996 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Keyword | chronic myeloproliferative disorder | dc.subject |
| Keyword | polycythemia vera | dc.subject |
| Keyword | erythropoietin | dc.subject |
| Keyword | clinical trial | dc.subject |
| Keyword | review | dc.subject |
| Keyword | chronic myeloproliferative disorders | dc.subject |
| Keyword | recombinant interferon-alpha | dc.subject |
| Keyword | chronic myelogenous leukemia | dc.subject |
| Keyword | essential thrombocythemia | dc.subject |
| Keyword | bone-marrow | dc.subject |
| Keyword | erythroid progenitors | dc.subject |
| Keyword | hydroxyurea | dc.subject |
| Keyword | transformation | dc.subject |
| Keyword | thrombosis | dc.subject |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| Title | The present state of pathophysiology and therapeutic trials in Polycythemia vera | dc.title |
| Resource type | Wissenschaftlicher Artikel | dc.type |
| Institution | UKU. Klinik für Innere Medizin III | uulm.affiliationSpecific |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| Source - Title of source | International Journal of Hematology | source.title |
| Source - Place of publication | Elsevier Science Ireland | source.publisher |
| Source - Volume | 64 | source.volume |
| Source - Issue | 3-4 | source.issue |
| Source - Year | 1996 | source.year |
| Source - From page | 153 | source.fromPage |
| Source - To page | 165 | source.toPage |
| Source - ISSN | 0925-5710 | source.identifier.issn |
| Open Access | No | uulm.OA |
| Community | Universitätsklinikum Ulm | uulm.community |
| WoS | A1996VT06000001 | uulm.identifier.wos |
| Bibliography | uulm | uulm.bibliographie |
